Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
New Best Practices, LLC Primary Research Study Highlights the Information that Pharma Field Medical Teams Should use to Influence Formulary Decisions | ||
By: PR Newswire Association LLC. - 11 Jan 2019 | Back to overview list |
|
CHAPEL HILL, N.C., Jan. 11, 2019 /PRNewswire/ -- What type of information has the biggest impact on formulary decisions at managed care organizations? "Outside of efficacy, safety and cost information? Nothing else really matters; everything else kind of goes into the bucket of 'Other,' like convenience, even compliance. It is not going to cut it, unless you can monetize it - whatever that information is. Translate into cost savings, or translate into clinical superiority – which is safety and efficacy - or it's just not going to work. Everything has to go back to clinical or cost," said a veteran Pharmacy Director at a large managed care organization. This is one of more than 40 narratives from 23 formulary leaders at 16 managed care organizations who participated in a study from research and consulting leader Best Practices, LLC. The new primary research study examines Field Medical Team (FMT) interactions with payers such as Humana and Aetna. "Best Practices in Formulary Success: Key Payer Responsibilities and the Information and Qualities they seek from Field Medical Teams" explores what types of information payers find most important for their formulary decision-making and how they are using the information related to formulary placement. In addition, this 98-page study seeks to understand payers' perceptions and experiences with pharma companies' field medical representatives. The research includes a chapter where payers rank 11 top pharma companies' field medical teams and explain why they ranked some high and others low. Topics addressed in this study include:
As the healthcare market shifts to a value-based system, a new product's position on a formulary is now as important as its reception among prescribers and KOLs. Recognizing this trend, pharma has been arming its FMTs with data from clinical studies, real world experiences, and other sources to not only justify formulary positioning but also to seek preferred status for their products. To learn more about this report, download a complimentary report excerpt at http://www.best-in-class.com/rr1525.htm. For related research, visit our Best Practices, LLC website at www.best-in-class.com. ABOUT BEST PRACTICES, LLC SOURCE Best Practices, LLC |
||
|
||
Copyright 2019 PR Newswire Association LLC. | Back to overview list |